Cheng Li

Cheng 'Cynthia' Li, PhD, is an accomplished professional in the biotechnology and pharmaceutical sectors with extensive experience in business development and innovation in the oncology space. Currently serving as Senior Director of External Innovation at Eli Lilly and Company since March 2025, prior roles include Vice President of Business Development at CytomX Therapeutics, Member at Chief, and Vice President of Business & Corporate Development at Spotlight Therapeutics. Cheng's industry experience also encompasses senior roles in business development at Exelixis and a managerial position at Amgen. Educational credentials include a Ph.D. in Molecular Cell Biology from Washington University in St. Louis and a BS in Biotechnology from Huazhong University of Science and Technology.